David Rowbotham
- Hepatology top 10%
- Gastroenterology top 5%
- Gastrointestinal motility and disorders 5
- Epidemiology top 10%
- Microscopic Colitis 17
- Pharmacology top 5%
- Genetics top 10%
- Inflammatory Bowel Disease 27
- Chronic Lymphocytic Leukemia Research 5
-
- Diverticular Disease and Complications 7
- Gastrointestinal disorders and treatments 5
- Enhanced Recovery After Surgery 4
- Diagnosis and treatment of tuberculosis 4
David Rowbotham
54 papers receiving 753 citations
Peers
Comparison fields: 5 of 86
- Hepatology 115
- Gastroenterology 79
- Epidemiology 330
- Pharmacology 83
- Genetics 231
Countries citing papers authored by David Rowbotham
This map shows the geographic impact of David Rowbotham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rowbotham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rowbotham more than expected).
Fields of papers citing papers by David Rowbotham
This network shows the impact of papers produced by David Rowbotham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rowbotham. The network helps show where David Rowbotham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Rowbotham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 24 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 46 | |
| 7 | 2020 | 29 | |
| 8 | 2020 | 0 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 1 | |
| 13 | 2018 | 34 | |
| 14 | 2016 | 2 | |
| 15 | 2012 | 1 | |
| 16 | 2007 | 15 | |
| 17 | 2006 | 20 | |
| 18 | 1998 | 148 | |
| 19 | 1997 | 8 | |
| 20 | 1995 | 75 |
About David Rowbotham
David Rowbotham is a scholar working on Gastroenterology, Genetics, Epidemiology, Hepatology and Genetics, having authored 58 papers that have together received 773 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (27 papers), Microscopic Colitis (17 papers), Diverticular Disease and Complications (7 papers), Gastrointestinal motility and disorders (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Gastrointestinal disorders and treatments (5 papers), Enhanced Recovery After Surgery (4 papers) and Diagnosis and treatment of tuberculosis (4 papers). The work is most often cited by research in Hepatology (115 citations), Gastroenterology (79 citations), Epidemiology (330 citations), Pharmacology (83 citations) and Genetics (231 citations). David Rowbotham has collaborated with scholars based in New Zealand, Australia and United States. Frequent co-authors include Julia Wendon, Robert W. Williams, L K Trejdosiewicz, P D Howdle, Ian Bissett, Philip Quirke, N Mapstone, Silvio Danese, Rupert W. Leong and Colleen Marano. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Gastrointestinal Endoscopy, The American Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.